% Expired Patents = 16.7

EPO Patents = 2

Forward Citations = 8

Loading Chart...

4 inventors (with patents filed for the assignee):

Antonio Francesco Di Naro (4 out of 12 patents)

Paolo Giuseppe Gobbi Frattini (1 out of 12 patents)

Francesco Tedesco (1 out of 5 patents)

4. Roberto Marzari (1 out of 4 patents)

6 patents: Sort by Forward Citations

1. 12583934 - ANTI-CD26 ANTIBODIES AND USES THEREOF (2026-03-24),

2. 12274671 - Sterile flexible package with pressure compensator for the dosed reconstitution of fluid medicinal or nutritional substances to be administered to patients by infusion or injection (2025-04-14),

3. 11959913 - Quantitative cellular method for determining the biological activity of an anti-CD26 ligand (2024-04-16),

4. 11242399 - Anti-CD26 antibodies (2022-02-08),

5. 9376498 - Anti-CD26 antibodies and uses thereof (2016-06-28),

6. 8962819 - Anti-C5 alpha antibodies (2015-02-24),

Adienne S.a. is a leading biotechnology company focused on the development and commercialization of novel therapies in the fields of oncology and rare diseases. With a strong dedication to innovation and patient care, Adienne S.a. is committed to bringing life-changing treatments to patients worldwide.

Profile summary based on public USPTO records.